Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 194

The DOI matches its Crossref record.

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF INFLIXIMAB IN PATIENTS WITH CHRONIC PULMONARY SARCOIDOSIS

Baughman, R.P., Judson, M.A., Costabel, U., duBois, R.M., Drent, M., Kavuru, M., Lo, K.H., Andresen, C., Schlenker-Herceg, R., Barnathan, E.S.·2005·Chest

Abstract

PURPOSES: Study a tumor necrosis factor receptor antagonist (etanercept) in the treatment of chronic ocular sarcoidosis. SUBJECTS AND METHODS: Eighteen patients with ocular sarcoidosis and ongoing inflammation in the eyes. All patients had received at least 6 months of therapy with methotrexate and were currently receiving corticosteroids. Patients were randomized to receive either etanercept, 25 mg subcutaneously twice a week, or placebo in a double-blind randomized trial. Treatment for ocular inflammation with systemic and local corticosteroids at the beginning and end of 6 months of treatment was noted. All patients underwent an ocular examination at the beginning and the end of the study by one ophthalmologist who was unaware of what treatment the patient was receiving. RESULTS: Three of the patients treated with etanercept and one treated with placebo were being treated with lower doses of corticosteroids by the end of the study. However, three of the etanercept patients and one of the placebo patients required larger doses of corticosteroids by the end of the study. The ophthalmology global assessment improved for two of the etanercept-treated patients and three of the placebo-treated patients. CONCLUSION: For most patients, therapy with etanercept was not associated with a significant improvement in their chronic ocular disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1378/chest.128.2.1062

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 194

Metadata

Authors
Baughman, R. P., Judson, M. A., Costabel, U., duBois, R. M., Drent, M., Kavuru, M., Lo, K. H., Andresen, C., Schlenker-Herceg, R., & Barnathan, E. S.
Venue
Chest
Publisher
Elsevier BV
Published
2005-10
Volume
128
Issue
4
Pages
202S
ISSN
0012-3692
OpenAlex
W1509005197
Cited by
194
References
0
FWCI
8.03
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF INFLIXIMAB IN PATIENTS WITH CHRONIC PULMONARY SARCOIDOSIS. https://app.cochat.ai/papers/10.1378/chest.128.2.1062
The paper
Baughman, R. P., Judson, M. A., Costabel, U., duBois, R. M., Drent, M., Kavuru, M., Lo, K. H., Andresen, C., Schlenker-Herceg, R., & Barnathan, E. S. (2005). RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF INFLIXIMAB IN PATIENTS WITH CHRONIC PULMONARY SARCOIDOSIS. Chest. https://doi.org/10.1378/chest.128.2.1062

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.